118 related articles for article (PubMed ID: 8525632)
1. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.
Huberman K; Peluso RW; Moscona A
Virology; 1995 Dec; 214(1):294-300. PubMed ID: 8525632
[TBL] [Abstract][Full Text] [Related]
2. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
[TBL] [Abstract][Full Text] [Related]
3. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
5. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.
Moscona A; Peluso RW
Microb Pathog; 1996 Mar; 20(3):179-84. PubMed ID: 8965678
[TBL] [Abstract][Full Text] [Related]
7. Persistent infection with human parainfluenza virus 3 in CV-1 cells: analysis of the role of defective interfering particles.
Moscona A; Peluso RW
Virology; 1993 May; 194(1):399-402. PubMed ID: 8386885
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.
Prince GA; Ottolini MG; Moscona A
J Virol; 2001 Dec; 75(24):12446-51. PubMed ID: 11711635
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein.
Dallocchio F; Tomasi M; Bellini T
Biochem Biophys Res Commun; 1994 Jun; 201(2):988-93. PubMed ID: 8003040
[TBL] [Abstract][Full Text] [Related]
10. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
[TBL] [Abstract][Full Text] [Related]
11. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion.
Moscona A; Peluso RW
J Virol; 1992 Nov; 66(11):6280-7. PubMed ID: 1328668
[TBL] [Abstract][Full Text] [Related]
12. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
[TBL] [Abstract][Full Text] [Related]
14. Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants.
Terrier O; Cartet G; Ferraris O; Morfin F; Thouvenot D; Hong SS; Lina B
J Clin Virol; 2008 Sep; 43(1):86-92. PubMed ID: 18579437
[TBL] [Abstract][Full Text] [Related]
15. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity.
Sergel T; McGinnes LW; Morrison TG
Virology; 1993 Oct; 196(2):831-4. PubMed ID: 8372451
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of interference mediated by human parainfluenza virus type 3 infection.
Horga MA; Gusella GL; Greengard O; Poltoratskaia N; Porotto M; Moscona A
J Virol; 2000 Dec; 74(24):11792-9. PubMed ID: 11090179
[TBL] [Abstract][Full Text] [Related]
17. A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein.
Yuasa T; Kawano M; Tabata N; Nishio M; Kusagawa S; Komada H; Matsumura H; Ito Y; Tsurudome M
Virology; 1995 Feb; 206(2):1117-25. PubMed ID: 7531915
[TBL] [Abstract][Full Text] [Related]
18. Human parainfluenza virus 3 neuraminidase activity contributes to dendritic cell maturation.
Horga MA; Macip S; Tuyama AC; Tan MC; Gusella GL
Viral Immunol; 2005; 18(3):523-33. PubMed ID: 16212531
[TBL] [Abstract][Full Text] [Related]
19. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function.
Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z
Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146
[TBL] [Abstract][Full Text] [Related]
20. Paramyxovirus fusion (F) protein and hemagglutinin-neuraminidase (HN) protein interactions: intracellular retention of F and HN does not affect transport of the homotypic HN or F protein.
Paterson RG; Johnson ML; Lamb RA
Virology; 1997 Oct; 237(1):1-9. PubMed ID: 9344902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
